Benjamin Gerald Tehan

Person

  • Welwyn Garden City, GB

Patents Grantslast 30 patents

Patents Applicationslast 30 patents

  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

    • Publication number 20240092754
    • Publication date Mar 21, 2024
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MUSCARINIC AGONISTS

    • Publication number 20230002354
    • Publication date Jan 5, 2023
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    OXIME COMPOUNDS AS AGONISTS OF THE MUSCARINIC M1 AND/OR M4 RECEPTOR

    • Publication number 20220298133
    • Publication date Sep 22, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED CYCLOHEXANES AS MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPT...

    • Publication number 20220213034
    • Publication date Jul 7, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OXEXIN 1 RECEPTOR ANTAGONISTS

    • Publication number 20220098165
    • Publication date Mar 31, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

    • Publication number 20220056009
    • Publication date Feb 24, 2022
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MUSCARINIC RECEPTOR AGONISTS

    • Publication number 20220048928
    • Publication date Feb 17, 2022
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OREXIN 1 RECEPTOR ANTAGONISTS

    • Publication number 20220041573
    • Publication date Feb 10, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    QUINOLINONE AND BENZOXAZINE DERIVATIVES AS MUSCARINIC M1 AND/OR M4...

    • Publication number 20220017504
    • Publication date Jan 20, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 AND/OR M4 RECEPTOR AGONISTS

    • Publication number 20210387969
    • Publication date Dec 16, 2021
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MUSCARINIC M1 RECEPTOR AGONISTS

    • Publication number 20210353637
    • Publication date Nov 18, 2021
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

    • Publication number 20210309632
    • Publication date Oct 7, 2021
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OX1 ANTAGONISTS

    • Publication number 20210179578
    • Publication date Jun 17, 2021
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PHARMACEUTICAL COMPOUNDS

    • Publication number 20210101893
    • Publication date Apr 8, 2021
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PHARMACEUTICAL COMPOUNDS

    • Publication number 20210040067
    • Publication date Feb 11, 2021
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    PHARMACEUTICAL COMPOUNDS

    • Publication number 20210002271
    • Publication date Jan 7, 2021
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    MUSCARINIC AGONISTS

    • Publication number 20200354339
    • Publication date Nov 12, 2020
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPTOR

    • Publication number 20200325118
    • Publication date Oct 15, 2020
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED CYCLOHEXANES AS MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPT...

    • Publication number 20200290963
    • Publication date Sep 17, 2020
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MUSCARINIC M1 RECEPTOR AGONISTS

    • Publication number 20200253982
    • Publication date Aug 13, 2020
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS

    • Publication number 20200172505
    • Publication date Jun 4, 2020
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OXIME COMPOUNDS AS AGONISTS OF THE MUSCARINIC M1 AND/OR M4 RECEPTOR

    • Publication number 20200165220
    • Publication date May 28, 2020
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    INHIBITORS OF PROTEASE-ACTIVATED RECEPTOR-2

    • Publication number 20200140392
    • Publication date May 7, 2020
    • Heptares Therapeutics Limited
    • John Graham Cumming
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    MUSCARINIC AGONISTS

    • Publication number 20200129496
    • Publication date Apr 30, 2020
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MUSCARINIC RECEPTOR AGONISTS

    • Publication number 20200017530
    • Publication date Jan 16, 2020
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PHARMACEUTICAL COMPOUNDS

    • Publication number 20200002328
    • Publication date Jan 2, 2020
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    PHARMACEUTICAL COMPOUNDS

    • Publication number 20190389849
    • Publication date Dec 26, 2019
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPTOR

    • Publication number 20190337925
    • Publication date Nov 7, 2019
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PHARMACEUTICAL COMPOUNDS

    • Publication number 20190276437
    • Publication date Sep 12, 2019
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    MUSCARINIC AGONISTS

    • Publication number 20190270718
    • Publication date Sep 5, 2019
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE